Cancer Treatment Centers of America® (CTCA) Phoenix is the first hospital in the western half of the U.S. and the first hospital in Arizona to utilize GI Genius – a powerful ally in the fight against colorectal cancer that employs artificial intelligence (AI) to help physicians detect polyps.
The GI Genius module uses advanced AI software to highlight suspicious polyps with a visual marker in real time—serving as the gastroenterologist’s ever-vigilant second observer with a sensitivity rate per lesion of 99.7%.1 Studies have shown that AI-assisted colonoscopy can increase polyp detection rates, and every 1% increase in adenoma detection rate reduces the risk of colorectal cancer by 3%.2,3 Colorectal cancer is the third most common form of cancer diagnosed in the U.S., with almost 150,000 new cases every year.
Trending
- Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn’s disease: 5-year follow-up of the PROFILE trial (The Lancet Gastroenterology & Hepatology)
- Low AST and ALT Levels Are Associated with Higher Likelihood of Early-Onset Colorectal Cancer in Adults Under 45 (Epic Research)
- Helicobacter pylori exposure linked to one in five cases of bowel cancer (News Medical)
- FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer (PR Newswire)
- A robot pill the size of a large vitamin swims through a stomach on 6 water jets while a doctor steers it with a game controller, and after $21 million it still cannot be used on a patient (The Pulse)
- GLP-1 users can have ‘terrific results’ with bariatric surgery to lose additional weight (Healio)
- GI faces another round of Medicare cuts under proposed 2027 rules (GI & Hepatology News)
- Fecal Occult Blood Screening Outcomes Adjusted for Contamination Bias and Nonadherence (JAMA Network)
